ADT INC. DL-,01/ US00090Q1031 /
5/22/2024 8:05:01 AM | Chg. +0.0500 | Volume | Bid9:07:23 AM | Ask9:07:23 AM | High | Low |
---|---|---|---|---|---|---|
6.7500EUR | +0.75% | 0 Turnover: 0.0000 |
6.7500Bid Size: 240 | 6.8000Ask Size: 240 | 6.7500 | 6.7500 |
GlobeNewswire
5/16
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benef...
GlobeNewswire
4/15
Shah Capital nominates two highly qualified independent director candidates for Novavax
GlobeNewswire
3/7
Health Gorilla Partners With Wheel to Extend Diagnostic Ordering Through Wheel’s Virtual Care Ecosys...
GlobeNewswire
3/7
ADT Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase
GlobeNewswire
3/6
ADT Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase
GlobeNewswire
2/28
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...
GlobeNewswire
11/15/2023
Atico Mining Reports Results on Brownfield Drilling Campaign to Extend Mine Life at El Roble High Gr...
GlobeNewswire
11/15/2023
USQHIN Announces Intention to Become a Qualified Health Information Network
GlobeNewswire
11/13/2023
Eyenovia Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
11/8/2023
ADT and Ford Backed Canopy Selects Ambarella’s Edge AI System-on-Chip for Groundbreaking Intelligent...
GlobeNewswire
11/6/2023
Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth;...
GlobeNewswire
11/2/2023
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update